Announcements Trials
Browse Landscape

Phase

Phase 1/2 1Phase 1 1

Status

Unknown 1Recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 35Gastrointestinal 5Thoracic 2Head & Neck 2Gynecologic 2Breast 2Sarcoma 1Plasma cell 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1Dermatologic 1Classical hematology 1

Conditions

Squamous Cell Carcinoma of Head and Neck 18Head and Neck Neoplasms 10Melanoma 9Carcinoma, Non-Small-Cell Lung 7Triple Negative Breast Neoplasms 6Carcinoma, Transitional Cell 6Uterine Cervical Neoplasms 5Stomach Neoplasms 5Colorectal Neoplasms 5Carcinoma, Renal Cell 5Carcinoma, Hepatocellular 5Small Cell Lung Carcinoma 4Pancreatic Neoplasms 4Ovarian Neoplasms 4Nasopharyngeal Carcinoma 4Carcinoma, Merkel Cell 4Thyroid Neoplasms 3Sarcoma 3Salivary Gland Neoplasms 3Endometrial Neoplasms 3Urinary Bladder Neoplasms 2Recurrence 2Prostatic Neoplasms 2Neoplasms 2Neoplasm Metastasis 2Mesothelioma 2Lymphoma 2Liver Neoplasms 2Histiocytoma, Malignant Fibrous 2Esophageal Neoplasms 2

Interventions

pembrolizumab 12Docetaxel 7durvalumab 5Gemcitabine 5Trastuzumab 4Radiotherapy 4Surveys and Questionnaires 3Magnetic Resonance Spectroscopy 3tremelimumab 2tisotumab vedotin 2pertuzumab 2motexafin gadolinium 2cemiplimab 2X-Rays 2TH 302 2Ritonavir 2Pemetrexed 2Nivolumab 2Ipilimumab 2Interviews as Topic 2Injections 2Immunoglobulin G 2Cryosurgery 2Cisplatin 2Bortezomib 2Biopsy 2Bariatric Surgery 2zenocutuzumab 1yeast-CEA vaccine 1vandetanib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Prostatic Neoplasms × Ipilimumab × Head & Neck × Clear all
NCT04954599 2025-10-07

Phase 1/2 Clinical Trial of CP-506 (HAP) in Monotherapy or With Carboplatin or ICI

Maastricht University Medical Center

Phase 1/2 Recruiting
126 enrolled
BreastGastrointestinalGenitourinaryGynecologicHead & Neck

Head and Neck Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Triple Negative Breast Neoplasms

NCT03098160 2017-10-30

Immunotherapy Study of Evofosfamide in Combination With Ipilimumab

Threshold Pharmaceuticals

Phase 1 Unknown
69 enrolled
DermatologicGastrointestinalGenitourinaryHead & Neck

Squamous Cell Carcinoma of Head and Neck, Hypoxia, Melanoma, Pancreatic Neoplasms, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡